The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostrum Oil&gas Regulatory News (NOG)

Share Price Information for Nostrum Oil&gas (NOG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.16
Bid: 5.16
Ask: 6.30
Change: 0.44 (8.32%)
Spread: 1.14 (22.093%)
Open: 5.58
High: 5.58
Low: 5.16
Prev. Close: 5.29
NOG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Nostrum Oil & Gas PLC

19 Feb 2020 12:00

RNS Number : 4458D
Peel Hunt LLP
19 February 2020
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Peel Hunt LLP

(b) Name of offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Nostrum Oil & Gas Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Nostrum Oil & Gas Plc

(d) Date dealing undertaken:

18 February 2020

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

 

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary Shares

Buy

68,438

12.89 GBx

11.21 GBx

Ordinary Shares

Sell

83,939

12.88 GBx

11.20 GBx

 

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

19 February 2020

Contact name:

Kathleen Lloyd

Telephone number:

0207 418 8911

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERFIFSDFDIALII
Date   Source Headline
30th Apr 20217:00 amRNSQ1 2021 Operational Update
27th Apr 20217:00 amRNS2020 Full Year Results
20th Apr 20214:41 pmRNSSecond Price Monitoring Extn
20th Apr 20214:36 pmRNSPrice Monitoring Extension
20th Apr 20218:03 amRNSExtension of Forbearance Agreement
16th Apr 20219:55 amRNSNotice of Revised Full Year Results Date
15th Apr 20214:40 pmRNSSecond Price Monitoring Extn
15th Apr 20214:35 pmRNSPrice Monitoring Extension
8th Apr 20214:41 pmRNSSecond Price Monitoring Extn
8th Apr 20214:36 pmRNSPrice Monitoring Extension
26th Mar 20214:41 pmRNSSecond Price Monitoring Extn
26th Mar 20214:35 pmRNSPrice Monitoring Extension
24th Mar 20214:40 pmRNSSecond Price Monitoring Extn
24th Mar 20214:35 pmRNSPrice Monitoring Extension
23rd Mar 20214:40 pmRNSSecond Price Monitoring Extn
23rd Mar 20214:36 pmRNSPrice Monitoring Extension
22nd Mar 20214:41 pmRNSSecond Price Monitoring Extn
22nd Mar 20214:36 pmRNSPrice Monitoring Extension
22nd Mar 20217:00 amRNSExtension of Forbearance Agreement
11th Mar 20219:45 amRNSReserves Update
2nd Mar 20214:41 pmRNSSecond Price Monitoring Extn
2nd Mar 20214:35 pmRNSPrice Monitoring Extension
25th Feb 20214:40 pmRNSSecond Price Monitoring Extn
25th Feb 20214:35 pmRNSPrice Monitoring Extension
24th Feb 20214:40 pmRNSSecond Price Monitoring Extn
24th Feb 20214:35 pmRNSPrice Monitoring Extension
10th Feb 20214:40 pmRNSSecond Price Monitoring Extn
10th Feb 20214:35 pmRNSPrice Monitoring Extension
5th Feb 20214:41 pmRNSSecond Price Monitoring Extn
5th Feb 20214:36 pmRNSPrice Monitoring Extension
4th Feb 20211:35 pmRNSTermination of Mayfair Relationship Agreement
29th Jan 20214:35 pmRNSPrice Monitoring Extension
29th Jan 20219:40 amRNSQ4 and FY20 Operational Update
26th Jan 20212:25 pmRNSGroup CEO and Director Appointment
5th Jan 20219:15 amRNSBoard Changes
4th Jan 20214:41 pmRNSSecond Price Monitoring Extn
4th Jan 20214:36 pmRNSPrice Monitoring Extension
30th Dec 20204:35 pmRNSPrice Monitoring Extension
9th Dec 20204:40 pmRNSSecond Price Monitoring Extn
9th Dec 20204:36 pmRNSPrice Monitoring Extension
19th Nov 20204:40 pmRNSSecond Price Monitoring Extn
19th Nov 20204:35 pmRNSPrice Monitoring Extension
18th Nov 20203:50 pmRNSForbearance Agreement Support Update
17th Nov 20207:00 amRNS9M 2020 Financial Results
13th Nov 20204:40 pmRNSSecond Price Monitoring Extn
13th Nov 20204:36 pmRNSPrice Monitoring Extension
4th Nov 20204:41 pmRNSSecond Price Monitoring Extn
4th Nov 20204:36 pmRNSPrice Monitoring Extension
2nd Nov 20204:40 pmRNSSecond Price Monitoring Extn
2nd Nov 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.